glp-1 obesity drug news today september 15 2025 Outlook for in 2026: From Consolidation to Acceleration Use of diabetes and anti-obesity

This is because, as we age or with chronic health issues, the homeostatic level decreases

For instance, people with chronic illnesses or those who take medications affecting liver function should talk to healthcare providers about their diet

GLP-1 receptor agonists like Semaglutide and Tirzepatide (a newer dual-acting drug) work by activating GLP-1 receptors, thereby amplifying its effects on insulin, appetite suppression, and digestion

What is the best injection for weight loss

If youd like to find out why we took profit on our MedTech shorts, or find out when we booked a +300% gain on CURV, read about how recent developments have informed our allocation etc